Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
1.350
-0.020 (-1.46%)
At close: Mar 15, 2026

EGX:MCRO Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
894.54519.97526.01729.61594.26
Revenue Growth (YoY)
72.04%-1.15%-27.91%22.78%38.04%
Cost of Revenue
285.3196.85230.36167.97120.39
Gross Profit
609.24323.12295.65561.64473.87
Selling, General & Admin
428.35274.82353.03314.18256.02
Other Operating Expenses
15.860.5926.579.9613.73
Operating Expenses
473.79311.09478.04327.29270.25
Operating Income
135.4512.03-182.39234.35203.62
Interest Expense
-34.43-60.65-29.48-13.48-8.15
Interest & Investment Income
9.395.771.982.81.06
Currency Exchange Gain (Loss)
11.48-14.233.68-0.06
Other Non Operating Income (Expenses)
---49.95--
EBT Excluding Unusual Items
121.89-42.85-245.62227.35196.46
Impairment of Goodwill
---21.42--
Gain (Loss) on Sale of Investments
-3.29---
Asset Writedown
---3--
Pretax Income
121.89-39.56-270.03227.35196.46
Income Tax Expense
6.07-1.512.653.4848.49
Earnings From Continuing Operations
115.82-38.04-272.64173.88147.97
Minority Interest in Earnings
-0.09-0.05-0.01-0.04-0.04
Net Income
115.73-38.1-272.65173.84147.93
Net Income to Common
115.73-38.1-272.65173.84147.93
Net Income Growth
---17.51%9.47%
Shares Outstanding (Basic)
570570564572577
Shares Outstanding (Diluted)
570570564572577
Shares Change (YoY)
-1.12%-1.46%-0.88%-
EPS (Basic)
0.20-0.07-0.480.300.26
EPS (Diluted)
0.20-0.07-0.480.300.26
EPS Growth
---17.09%11.40%
Free Cash Flow
118.51-86.76-44.44129.6344.44
Free Cash Flow Per Share
0.21-0.15-0.080.230.08
Dividend Per Share
---0.1070.069
Dividend Growth
---54.70%-
Gross Margin
68.11%62.14%56.21%76.98%79.74%
Operating Margin
15.14%2.31%-34.67%32.12%34.26%
Profit Margin
12.94%-7.33%-51.83%23.83%24.89%
Free Cash Flow Margin
13.25%-16.69%-8.45%17.77%7.48%
EBITDA
140.4216.6-175.19237.89206.04
EBITDA Margin
15.70%3.19%-33.31%32.61%34.67%
D&A For EBITDA
4.974.577.23.542.42
EBIT
135.4512.03-182.39234.35203.62
EBIT Margin
15.14%2.31%-34.67%32.12%34.26%
Effective Tax Rate
4.98%--23.52%24.68%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.